Kenji Wada-Isoe

Kenji Wada-Isoe

Auto-generated profile, based on publicly available information

Kenji Wada-Isoe

Department of Dementia Research, Kawasaki Medical School, Kita-ku, Okayama, Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2012 in Dementia and Geriatric Cognitive Disorders Extra
Verified
Journal Article
Open access
PDF file
KWKenji Wada-Isoe
Kenji Wada-Isoe
YUYusuke Uemura
Yusuke Uemura
SNSatoko Nakashita
Satoko Nakashita
MYMika Yamawaki
Mika Yamawaki
KTKenichiro Tanaka
Kenichiro Tanaka
KNKenji Nakashima
Kenji Nakashima
Aims: In order to determine the prevalence of dementia and mild cognitive impairment (MCI), we conducted a population-based study in Japan. Methods: Participants included 924 subjects aged 65 years or older who resided in the town of Ama-cho. In phase 1 of the study, the Mini-Mental State Examination and Clinical Dementia Rating were administered for screening purposes. In phase 2 of the study, the subjects who screened positive were further examined by neurologists. Dementia and MCI were diagnosed by means of DSM-IV and International Working Group on MCI criteria, respectively. Results: By the prevalence date of June 1, 2010, 24 subjects had deceased or lived outside the town. In total, 723 of the remaining 900 subjects received a phase 1 test. In phase 2, 98 subjects were diagnosed with amnestic MCI, 113 subjects with non-amnestic MCI, and 82 subjects with dementia. Of the subjects who did not receive the phase 1 test, 66 subjects were diagnosed as having dementia according to data from their town medical card or the Long-term Care Insurance System. The crude prevalence of amnestic MCI, non-amnestic MCI, and dementia were 10.9, 12.6, and 16.4%, respectively. Conclusion: Consistent with the striking increase in the number of elderly individuals, we report higher prevalence of MCI and dementia in Japan than previously described.

27 November 2008 in Neuroepidemiology
Verified
Journal Article
Closed access
PDF file
KWKenji Wada-Isoe
Kenji Wada-Isoe
YUYusuke Uemura
Yusuke Uemura
YSYutaka Suto
Yutaka Suto
KDKoji Doi
Koji Doi
KIKeiko Imamura
Keiko Imamura
KNKenji Nakashima
Kenji Nakashima
Background: With the striking increase in the number of elderly people in Japan, dementia has not only become a medical but also a social issue. Methods: We studied the prevalence of dementing disorders in a rural island town of Japan (Ama-cho), using a door-to-door 2-phase design. Results: Of the 120 persons screened as having cognitive impairment, 104 people were diagnosed as having dementia. The prevalence (cases/100 persons aged 65 years and older) was 11.0 for all types of dementia, 7.0 for Alzheimer’s disease, 1.7 for vascular dementia, 0.53 for dementia with Lewy bodies, 0.74 for Parkinson’s disease dementia, 0.21 for progressive supranuclear palsy, 0.11 for frontotemporal lobar degeneration and 0.74 for other dementia. The overall prevalence was higher in women for Alzheimer’s disease and Parkinson’s disease dementia, and in men, for vascular dementia and dementia with Lewy bodies. Conclusion: We confirmed the overall prevalence of dementia in the elderly population aged 65 years and older to be 11.0. This finding is higher compared with previous reports in Japan.

19 November 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
KWKenji Wada-Isoe
Kenji Wada-Isoe
KTKikuchi Takashi
Kikuchi Takashi
YUYumi Umeda-Kameyama
Yumi Umeda-Kameyama
TMTakahiro Mori
Takahiro Mori
MAMasahiro Akishita
Masahiro Akishita
OGon behalf of the ABC Dementia Scale Research Group
on behalf of the ABC Dementia Scale Research Group
The course of Alzheimer’s disease (AD) varies between individuals, and the relationship between cognitive and functional decline and the deterioration of behavioral and psychological symptoms of dementia (BPSD) is still poorly understood. Until recently, it was challenging to monitor subsequent changes in these symptoms because there was no single composite scale available that could simultaneously evaluate activities of daily living (ADL), BPSD, and cognitive function (CF) states. The present authors developed a new, brief assessment scale, the “ABC Dementia Scale” (ABC-DS), which is based on item response theory and facilitates concurrent measurement of ADL, BPSD, and CF states. We previously presented the reliability, construct validity, concurrent validity, and responsiveness of the ABC-DS. We obtained the evidence through three clinical trials featuring 1,400 subjects in total. In the present study, we performed a secondary analysis of the data obtained in the previous study. We conducted hierarchical cluster analyses that allowed us to classify 197 AD patients in terms of similarities regarding ADL, BPSD, and CF domain scores, as measured by the ABC-DS. Consequently, the scale identified subgroups of patients with global clinical dementia ratings of 1, 2, and 3. Considering our results in conjunction with the clinical experiences of the AD expert among the present authors regarding longitudinal changes in ADL, BPSD, and CF, we were able to propose potential progression pathways of AD in the form of a hypothetical roadmap.

19 September 2012 in Dementia and Geriatric Cognitive Disorders Extra
Verified
Journal Article
Open access
PDF file
KWKenji Wada-Isoe
Kenji Wada-Isoe
SISatoru Ito
Satoru Ito
TATadashi Adachi
Tadashi Adachi
MYMika Yamawaki
Mika Yamawaki
SNSatoko Nakashita
Satoko Nakashita
KNKenji Nakashima
Kenji Nakashima
Background: The prevalence of frontotemporal lobar degeneration (FTLD) in Japan is unknown. An epidemiological survey study of FTLD was undertaken in Tottori Prefecture, a district in the western region of Japan. Methods: Hospitals in Tottori Prefecture were surveyed by a two-step questionnaire in 2010, and the prevalence of FTLD per 100,000 inhabitants was calculated using the actual number of patients and inhabitants in Tottori Prefecture on the prevalence day of October 1, 2010. Results: In this survey, 66 patients were diagnosed with FTLD. The subtypes of FTLD were as follows: 62 cases of frontotemporal dementia (FTD), 3 cases of progressive nonfluent aphasia, and 1 case of semantic dementia. Among the FTD cases, 5 cases were FTD with motor neuron disease and 1 case was FTD with parkinsonism linked to chromosome 17. The prevalence of FTD in the total population of Tottori Prefecture was 11.2 per 100,000 inhabitants. Based on these results, the prevalence of FTLD in Japan in 2008 was estimated to be 9.5 per 100,000 individuals. Conclusions: Our epidemiological survey results suggest that there are at least 12,000 FTLD patients in Japan, indicating that FTLD is not a rare disease.

1 March 2016 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
KWKenji Wada-Isoe
Kenji Wada-Isoe
KTKen-ichiro Tanaka
Ken-ichiro Tanaka
YUYusuke Uemura
Yusuke Uemura
SNSatoko Nakashita
Satoko Nakashita
YTYuki Tajiri
Yuki Tajiri
KNKenji Nakashima
Kenji Nakashima

14 August 2008 in Neurocase
Verified
Journal Article
Closed access
KIKeiko Imamura
Keiko Imamura
KWKenji Wada-Isoe
Kenji Wada-Isoe
HKHisanori Kowa
Hisanori Kowa
YTYoshio Tanabe
Yoshio Tanabe
KNKenji Nakashima
Kenji Nakashima
It has been reported that the cholinesterase inhibitor, donepezil, improves cognitive decline in patients with Parkinson's disease dementia (PDD). However, this improvement was dominant for frontal lobe dysfunction, and the increase in the Mini-Mental State Examination (MMSE) score was minimal. We report a PDD patient with a decline of regional cerebral blood flow (rCBF) in the posterior cingulate cortex, precunei, and bilateral parietotemporal association cortex, as determined by single-photon emission computed tomography (SPECT) using the easy Z-scores imaging system (e-ZIS). Upon administration of donepezil, both the rCBF and MMSE score increased. The effectiveness of donepezil may vary based on the rCBF pattern in PDD.